ACTUS Biotechnologies has added Ms. Tanya Paschke as their new Director of Operations. Ms. Paschke’s career includes more than 25 years of experience in the biopharmaceutical industry with roles of increasing responsibility in operational management of facilities, core research and development efforts and sales and marketing in major pharmaceutical and academic institutions.
About ACTUS Biotechnologies
ACTUS Biotechnologies is an accelerator company, commercializing the most impactful biopharmaceutical technologies; bridging the gap between academic research and industrial commercialization. The ACTUS Biotechnologies management team includes an exceptional team of individuals with decades of expertise in all aspects of the Life Sciences business sector. The team’s singular mission is the rapid growth and commercialization of technologies that have the potential to positively impact both the practice of medicine and patient quality of life; driven by innovation, forward thinking, integrity and empowerment.
During its licensing process, the ACTUS team performs extensive review and due diligence, ensuring the technology meets ACTUS’ standard of excellence. Licensed technologies are spun off into new, wholly-owned subsidiaries and provided with initial capital, and all operational support required to accelerate commercialization including: Operations, Research & Development, Project Planning, Business Development, and Legal. Current subsidiaries within the accelerator include Convoy Therapeutics (http://www.convoytx.com) and EnduRx Pharmaceuticals (
Copyright©2012 Vocus, Inc.
All rights reserved